Cohen Joshua B (CIK 1898644) reported 14 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-09). Recent activity: Buy AMLX (248,865 shares), Sell AMLX (29,282 shares), Sell AMLX (15,500 shares), Buy AMLX (197,182 shares), Sell AMLX (136,193 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-09 | Amylyx Pharmaceuticals, Inc. (AMLX) | Co-Chief Executive Officer | Buy | 248,865 | $0 |
| 2026-03-04 | Amylyx Pharmaceuticals, Inc. (AMLX) | Co-Chief Executive Officer | Sell | 29,282 | $424,003 |
| 2026-02-04 | Amylyx Pharmaceuticals, Inc. (AMLX) | Co-Chief Executive Officer | Sell | 15,500 | $227,540 |
| 2026-01-20 | Amylyx Pharmaceuticals, Inc. (AMLX) | Co-Chief Executive Officer | Buy | 197,182 | $1.5M |
| 2026-01-20 | Amylyx Pharmaceuticals, Inc. (AMLX) | Co-Chief Executive Officer | Sell | 136,193 | $1.9M |
| 2026-01-20 | Amylyx Pharmaceuticals, Inc. (AMLX) | Co-Chief Executive Officer | Buy | 2,818 | $21,332 |
| 2026-01-20 | Amylyx Pharmaceuticals, Inc. (AMLX) | Co-Chief Executive Officer | Sell | 1,974 | $27,300 |
| 2026-01-08 | Amylyx Pharmaceuticals, Inc. (AMLX) | Co-Chief Executive Officer | Sell | 7,715 | $85,559 |
| 2025-10-02 | Amylyx Pharmaceuticals, Inc. (AMLX) | Co-Chief Executive Officer | Sell | 29,733 | $426,371 |
| 2025-10-02 | Amylyx Pharmaceuticals, Inc. (AMLX) | Co-Chief Executive Officer | Sell | 200 | $3,000 |
| 2025-04-02 | Amylyx Pharmaceuticals, Inc. (AMLX) | Co-Chief Executive Officer | Sell | 21,490 | $74,570 |
| 2025-03-10 | Amylyx Pharmaceuticals, Inc. (AMLX) | Co-Chief Executive Officer | Buy | 180,118 | $0 |
| 2025-03-05 | Amylyx Pharmaceuticals, Inc. (AMLX) | Co-Chief Executive Officer | Sell | 4,595 | $14,566 |
| 2025-02-05 | Amylyx Pharmaceuticals, Inc. (AMLX) | Co-Chief Executive Officer | Sell | 11,851 | $41,123 |
Source: SEC Form 4 filings · as of 2026-03-09